Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
32.52
-1.68 (-4.91%)
At close: Nov 6, 2026, 4:00 PM EST
32.68
+0.16 (0.48%)
After-hours: Nov 6, 2026, 7:59 PM EST
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $1 billion as of November 6, 2026. It is the 9,883rd most valuable company in the world and the 2,214th biggest in the United States. Its market cap has increased by 2.28% in one year.
Market Cap
1.00B
Enterprise Value
761.12M
1-Year Change
2.28%
Global Rank
Country Rank
#2,214 United States
Category
ChartMarket Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $1.00B, an increase of 714.47%. That is a compound annual growth rate of 33.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.00B | -11.73% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sotera Health Company | 4.53B |
| Adaptive Biotechnologies | 4.34B |
| CareDx | 4.01B |
| NeoGenomics | 2.13B |
| Veracyte | 1.93B |
| GeneDx Holdings | 1.92B |
| Personalis | 1.66B |
| OPKO Health | 1.31B |